<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 12-Sep-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (12-Sep-2025)</h1>
<h2>Top News Bullets</h2>
<ul>
<li><strong>Increasing political violence in the US:</strong> Charlie Kirk assassination and related fallout putting focus on national security, public unrest, and social media conduct; broader fears in Congress for safety and surging politicization in schools and workplaces.</li>
<li><strong>Brazil political shock:</strong> Ex-president Jair Bolsonaro receives a 27-year prison sentence for coup plotting, straining Brazil-US relations as US politicians threaten re-evaluations of policy.</li>
<li><strong>Rising geopolitical friction:</strong> Russia triggers NATO alert after drone incursions, escalating East-West tensions and wariness over defense readiness.</li>
<li><strong>US economic cross-currents:</strong> Higher inflation (2.9% YoY), rising jobless claims, and mainstream concern over stagflation. Fed independence and governance challenged legally by Trump campaign.</li>
<li><strong>China-Mexico-US trade triangle:</strong> Mexico imposes steep tariffs on Chinese goods under US pressure, China warns of retaliatory measures; watch for ripple effects in North American manufacturing, autos, and broader US-China trade dynamics.</li>
<li><strong>Major M&amp;A rumblings:</strong> Paramount/Skydance preparing a bid for Warner Bros Discovery. Potential media consolidation could accelerate content/IP arms races and affect related equities.</li>
<li><strong>Tech and healthcare product headlines:</strong> Apple launches new iPhone, Watch, and gets FDA nod for hypertension alerts. FTC launches probe into AI chatbot safety (Meta, OpenAI, xAI, Snap).</li>
<li><strong>Starship/SpaceX milestones:</strong> High likelihood of 160+ launches next year, &lt;10% for &gt;180 launches or 7+ Starship launches.</li>
<li><strong>Crypto regulation:</strong> High probability of Ripple and Doge ETF approvals, but minimal likelihood of major direct US government Bitcoin reserves.</li>
</ul>
<hr />
<h2>Macro</h2>
<h3>Fed &amp; US Economy</h3>
<ul>
<li>Investors widely expect multiple Fed rate cuts in 2025 (2-3 cuts most likely), with almost no expectation of hikes or emergency cuts. Markets are betting against both US recession and a marketwide crash (~10% risk).
<ul>
<li><strong>Implication:</strong> Real rates are expected to slowly fall, supporting equities, growth companies, real estate, and longer-duration assets. Stagflation narrative (headline inflation rising, weakening jobs data) is gaining traction, which may introduce rate path volatility or slower cuts than anticipated. If labor market continues weakening, cuts may come sooner or deeper.</li>
<li><strong>Second Order:</strong> With political and legal interference attempts (e.g., Trump vs Lisa Cook), expect periodic Fed communication risks and policy uncertainty.</li>
</ul>
</li>
</ul>
<h3>Geopolitics &amp; Trade</h3>
<ul>
<li><strong>US-Brazil relations:</strong> The Bolsonaro ruling may disrupt political/economic relationships and spark secondary political instability in Latin America (ripple risks in emerging market ETFs, grain/commodity markets, agribusiness, USD/BRL volatility).</li>
<li><strong>NATO-Russia Tensions:</strong> Russian provocation at NATO borders increases defense sector tailwinds and keeps volatility premium elevated in energy/commodities.</li>
<li><strong>North American Trade:</strong> The newly aggressive Mexican tariffs against Chinese imports (especially autos) in response to US lobbying could re-shape supply chains, benefit American/Canadian manufacturers, and strain global industrials exposed to China.
<ul>
<li><strong>Third Order:</strong> If China responds, risk of tit-for-tat measures with implications for multinational earnings, input costs, and FX; monitor USDCNY and USDMXN.</li>
</ul>
</li>
<li><strong>US Political Violence:</strong> Ongoing high-profile shootings and school incidents highlight growing domestic instability risks. While unlikely to drive immediate market-wide moves, may slowly impact consumer and business confidence, especially in sectors like insurance, security, and social platforms.</li>
</ul>
<hr />
<h2>Sectors</h2>
<h3>Technology</h3>
<ul>
<li><strong>Megacap Tech:</strong> NVIDIA is the front-runner to remain the world's largest company by market cap into year-end, with Apple and Microsoft holding distant chances. The AI platform arms race is dominated by OpenAI, with xAI having an outside chance of taking the lead. Regulatory risks rise as the FTC investigates major AI firms for chatbot safety, pressing on names like Meta, Alphabet, OpenAI, and xAI.</li>
<li><strong>Consumer Electronics:</strong> Apple launches new AI-enabled iPhones and Watch with hypertension monitoring (FDA approved), pushing further into digital health and premium hardware.
<ul>
<li><strong>Third Order:</strong> Strengthens Apple’s competitive moat in both device and health ecosystems; likely to pressure rivals (Samsung, Google hardware), and may support digital health/insurer adoption.</li>
</ul>
</li>
<li><strong>Media &amp; Content:</strong> Prospective Paramount/Skydance bid for Warner Bros. Discovery could drive revaluation in content/IP stocks and encourage further M&amp;A; monitor leverage and competitive response.</li>
<li><strong>Crypto:</strong> Strong regulatory momentum for spot ETF approvals (Ripple, Doge) but little sign of direct Treasury Bitcoin reserves. Bitcoin itself has strong odds of breaking $130k relatively soon, but the $1M &quot;supercycle&quot; price is still a remote possibility.</li>
<li><strong>AI/Software:</strong> Potential regulatory headwinds (FTC) for both leading and upstart AI players, especially those targeting consumer and youth markets.</li>
</ul>
<h3>Aerospace &amp; Defense</h3>
<ul>
<li>SpaceX on track for exceptional launch year (expectation centering on 160-179 launches, strong likelihood of 4-6 Starship successes). Accelerated cadence could boost private space, satellite, and defense-adjacent suppliers.
<ul>
<li><strong>Third Order:</strong> Expanding space presence supports downstream industries—telecom, earth observation, launch services—and national security.</li>
</ul>
</li>
</ul>
<h3>Healthcare</h3>
<ul>
<li>Apple’s hypertension alert product validates digital diagnostics in wearables, boosting related device stocks. A breakthrough cystic fibrosis drug has earned major recognition; potential for sustained outperformance among biotechs with life-extension treatments.</li>
<li>Covid, measles, and West Nile news suggest continued attention on infectious disease and vaccine makers, though no immediate new shock is evident.</li>
</ul>
<h3>Energy &amp; Commodities</h3>
<ul>
<li>Limited immediate concern about climate or extreme weather in markets right now, despite ongoing global warming trend and record-breaking years. Energy sector outlook remains more closely tied to geopolitics (Russia-NATO, China trade), not crisis events.</li>
</ul>
<hr />
<h2>Individual Names</h2>
<ul>
<li><strong>NVIDIA (NVDA):</strong> Clear favorite to end the year as globe's largest market cap company, AI/server tailwinds remain exceptionally strong.</li>
<li><strong>Apple (AAPL):</strong> New hardware, regulatory moves (FDA, EU) could drive incremental upside; watch for initial demand/upgrade cycle trends.</li>
<li><strong>Meta/Alphabet/MSFT:</strong> Facing AI regulatory scrutiny but less likely to overtake NVDA in cap; ongoing content, AI, and cloud ambitions still in focus.</li>
<li><strong>SpaceX:</strong> Private, but high launch cadence could spur interest in public comps and related telecom/satellite suppliers.</li>
<li><strong>Warner Bros Discovery, Paramount:</strong> All eyes on bid outcome—ripples for all US media conglomerates, M&amp;A arb strategies active.</li>
</ul>
<hr />
<h2>Strategic Takeaways</h2>
<ul>
<li><strong>Macro environment continues to favor risk assets:</strong> Barring unexpected shocks, easy monetary policy and a low probability of recession drive a constructive backdrop for growth stocks and duration-sensitive sectors.</li>
<li><strong>Monitor latent tail risks:</strong> Political violence and legal drama around the Fed translate into background volatility but not immediate flight-to-safety flows.</li>
<li><strong>Tactical sector biases:</strong> Stay overweight US technology and aerospace/defense; keep underweight in China-exposed industrials and policy-vulnerable EM due to new trade friction.</li>
<li><strong>Selected headline risk in healthcare, consumer and media from regulatory and product launches.</strong></li>
<li><strong>Crypto remains speculative but institutionalization (ETF, custody) is ongoing; upside remains in play, but avoid hyper-bullish positioning.</strong></li>
</ul>
<hr />
<p><strong>Prepared for investment review as of 12-Sep-2025.</strong></p>

</main>
</body>
</html>
